Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FAST kinase domains 3 pseudogene (LOC100419318; ENSG00000250037) is a genomic DNA sequence with high similarity to the coding gene FASTKD3 but is classified as a **pseudogene**. Pseudogenes like this do not encode active proteins and do not participate in cellular signaling, enzyme activity, or drug targeting. The functional analog, FASTKD3 (FAST kinase domain-containing protein 3), is a mitochondrial protein involved in the assembly or regulation of respiratory chain complexes and mitochondrial mRNA processing, but the pseudogene is biologically inactive[1][5][6]. Key notes: - This entry should not be confused with the functional FASTKD3 gene/protein, which is a mitochondrial protein involved in energy balance and RNA processing[1][2][6]. - The **pseudogene** status means it does not encode a therapeutic target and has *no established biological, pharmacological, or clinical significance*.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FAST kinase domains 3 pseudogene.